#$%^&*AU2013203825B220151217.pdf#####34 ABSTRACT The invention relates to the treatment of an inflammatory or immune disorder with a pharmaceutical composition including methylsulphonylmethane, glucosamine and glycine or pharmaceutically acceptable salts or derivatives of these 5 compounds.